P McElwaine1,2,3, J McCormack4,5,6, C Brennan4,7, H Coetzee8, P Cotter8, R Doyle8, A Hickey9, F Horgan9, C Loughnane6, C Macey6, P Marsden7, D McCabe5,10, R Mulcahy11, I Noone8, E Shelley7, T Stapleton5, D Williams9, P Kelly4,8, J Harbison4,5,10. 1. National Clinical Programme for Stroke, Health Service Executive, Dublin, Ireland. mcelwaip@tcd.ie. 2. Trinity College, University of Dublin, Dublin, Ireland. mcelwaip@tcd.ie. 3. Department of Medical Gerontology, Trinity College Dublin, Mercer's Institute, St James's Hospital, Dublin, D08 RT2X, Ireland. mcelwaip@tcd.ie. 4. National Clinical Programme for Stroke, Health Service Executive, Dublin, Ireland. 5. Trinity College, University of Dublin, Dublin, Ireland. 6. Irish Heart Foundation, Dublin, Ireland. 7. Department of Public Health, Health Service Executive, Tullamore, Ireland. 8. Ireland East Hospitals Group and University College Dublin, Dublin, Ireland. 9. Royal College of Surgeons of Ireland, Dublin, Ireland. 10. Dublin Midlands Hospitals Group, Dublin, Ireland. 11. South/South West Hospitals Group, Waterford, Ireland.
Abstract
BACKGROUND: In the setting of a national audit of acute stroke services, we examined the delivery of thrombolytic therapy for ischaemic stroke and whether current practice was achieving safe outcomes and consistent delivery for patients. METHOD: Data obtained from the recent national stroke audit was compared against previous Irish audit, the most recent SSNAP UK stroke audit and the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) study. RESULTS: Thrombolysis was provided in 27 acute hospitals throughout Ireland during the period assessed with 82% (22/27) providing 24/7 access, the remaining sites using redirect policies. Decision to thrombolyse was made by stroke trained consultants in 63% (17/27) of units, with general physicians and emergency medicine consultants covering the other units. Thrombolysis rate for non-haemorrhagic stroke was 11% (n = 80/742, CI 95% ±2.23) versus a 1% rate in the 2008 audit. Sites receiving patients through a redirect policy had the highest thrombolysis rate, an average of 24%. Nearly 30% of cases were thrombolysed on the weekend. Eighty-three percent of cases were managed in a stroke unit at some time during admission versus 54% of the national total cases. Thirty-seven percent of patients were ≥80 years old. The mortality rate was 11.3% versus the national mortality rate for non-thrombolysed ischaemic strokes of 10% (p > 0.5), and this is comparable to the SITS-MOST 2007 study 3-month mortality rate of 11.3% (p > 0.5). CONCLUSION: Stroke thrombolysis is being effectively and safely provided in acute stroke services in Ireland despite regular involvement of non-specialist staff. There is still potential to improve thrombolysis rate.
BACKGROUND: In the setting of a national audit of acute stroke services, we examined the delivery of thrombolytic therapy for ischaemic stroke and whether current practice was achieving safe outcomes and consistent delivery for patients. METHOD: Data obtained from the recent national stroke audit was compared against previous Irish audit, the most recent SSNAP UK stroke audit and the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) study. RESULTS: Thrombolysis was provided in 27 acute hospitals throughout Ireland during the period assessed with 82% (22/27) providing 24/7 access, the remaining sites using redirect policies. Decision to thrombolyse was made by stroke trained consultants in 63% (17/27) of units, with general physicians and emergency medicine consultants covering the other units. Thrombolysis rate for non-haemorrhagic stroke was 11% (n = 80/742, CI 95% ±2.23) versus a 1% rate in the 2008 audit. Sites receiving patients through a redirect policy had the highest thrombolysis rate, an average of 24%. Nearly 30% of cases were thrombolysed on the weekend. Eighty-three percent of cases were managed in a stroke unit at some time during admission versus 54% of the national total cases. Thirty-seven percent of patients were ≥80 years old. The mortality rate was 11.3% versus the national mortality rate for non-thrombolysed ischaemic strokes of 10% (p > 0.5), and this is comparable to the SITS-MOST 2007 study 3-month mortality rate of 11.3% (p > 0.5). CONCLUSION:Stroke thrombolysis is being effectively and safely provided in acute stroke services in Ireland despite regular involvement of non-specialist staff. There is still potential to improve thrombolysis rate.
Entities:
Keywords:
Ischaemic stroke; National Audit; Patient safety; Service organisation; Stroke; Thrombolysis
Authors: Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren Journal: Lancet Date: 2007-01-27 Impact factor: 79.321
Authors: Craig S Anderson; Thompson Robinson; Richard I Lindley; Hisatomi Arima; Pablo M Lavados; Tsong-Hai Lee; Joseph P Broderick; Xiaoying Chen; Guofang Chen; Vijay K Sharma; Jong S Kim; Nguyen H Thang; Yongjun Cao; Mark W Parsons; Christopher Levi; Yining Huang; Verónica V Olavarría; Andrew M Demchuk; Philip M Bath; Geoffrey A Donnan; Sheila Martins; Octavio M Pontes-Neto; Federico Silva; Stefano Ricci; Christine Roffe; Jeyaraj Pandian; Laurent Billot; Mark Woodward; Qiang Li; Xia Wang; Jiguang Wang; John Chalmers Journal: N Engl J Med Date: 2016-05-10 Impact factor: 91.245
Authors: Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni Journal: N Engl J Med Date: 2008-09-25 Impact factor: 91.245
Authors: E Bernd Ringelstein; Angel Chamorro; Markku Kaste; Peter Langhorne; Didier Leys; Philippe Lyrer; Vincent Thijs; Lars Thomassen; Danilo Toni Journal: Stroke Date: 2013-01-29 Impact factor: 7.914
Authors: Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz Journal: Lancet Date: 2012-05-23 Impact factor: 79.321